MedPath

Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias

Phase 4
Recruiting
Conditions
Postoperative Analgesia
S-ketamine
Pediatrics
Caudal Block
Hypospadias
Interventions
Registration Number
NCT05922605
Lead Sponsor
Tao Zhang
Brief Summary

Caudal analgesia with ropivacaine is commonly used in sub-umbilical pediatric surgery. However, increasing the dosage of ropivacaine has not been found to prolong the action significantly while complications will be serious.

Ketamine as an additive to caudal administration had been shown to prolong the duration of postoperative analgesia, while the analgesic effectiveness of S-ketamine, the S(+)-enantiomer of ketamine with less possibility to induce psychomotor disturbances, is not clear. In this prospective randomized double-blind clinical trial , the investigators aimed to study the effect of S-ketamine as additive on the duration of caudal analgesia.

Detailed Description

Forty-four children scheduled for hypospadias randomize into 2 groups. Group E (n=22) (0.2% ropivacaine 0.7 ml/kg and S-ketamine 0.5 mg/kg), group C(n=22)( 0.2%ropivacaine 0.7ml/kg and equivalent saline) intraoperative and postoperative hemodynamics will be recorded. Postoperative pain is assessed using an established 6-item FLACC score at 1h,3h,6h,12h,24h,48h, or the time when children complain of pain after surgery. A score of more15μg/kg is administered.Investigators propose to compare the duration of caudal analgesia provided by plain ropivacaine and by a mixture of ropivacaine and S-ketamine.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
44
Inclusion Criteria
  • informed parent consent, ASA I or II children, between 3months and 18 years of age,and weighing <28kg, scheduled for elective hypospadias surgery with general anesthesia will be recruited.
Exclusion Criteria
  • Patients who have congenital abnormalities of lower spine and meninges.
  • Patients with hypersensitivity to any local anesthetics
  • Children with coagulation disorders
  • Presence of Infections at puncture sites
  • Preexisting neurological disease
  • Refusal to consent by parent/guardian

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group ES-ketamine & Ropivacainethe children are given a mixture of 0.2%ropivacaine 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg for caudal analgesia.
Group CRopivacaineThe children are given 0.2%ropivacaine 0.7 ml/kg and saline of equal volume caudally.
Primary Outcome Measures
NameTimeMethod
duration of caudal analgesia48 hours after the caudal injection

Duration of analgesia is defined as the time from caudal injection to the first need for systemic analgesia.

Secondary Outcome Measures
NameTimeMethod
FLACC score48 hours after the caudal block

The Face, Legs, Activity, Cry, and Consolability (FLACC) scale

morphine consumption48 hours after caudal block

The Face, Legs, Activity, Cry, and Consolability (FLACC) scale at 1 hour (h), 3h,6h,12h,24h,48h or the time when children complain of pain after surgery. A score of more than 3 points is taken as an indication of inadequate analgesia and morphine 15ug/kg was administered .

complication48 hours after the caudal block

the incidence of residual motor block, urinary retention, paraesthesia; the incidence of respiratory depression ,vomiting ,nystagmus ,pruritus,odd behavior;.the sedation scores etc.

Trial Locations

Locations (1)

First Affiliated Hospital, Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath